Type 2 & other diabetes

The effect of once-weekly insulin icodec vs once-daily basal insulin on physical activity-attributed hypoglycaemia in type 2 diabetes: a post hoc analysis of ONWARDS 1–5

DiabetologiaPublished Post hoc analysis of the ONWARDS 1–5 randomised trials

Authors' conclusion

These findings do not suggest that there is an additional increase in hypoglycaemia risk attributed to physical activity with once-weekly basal icodec vs once-daily basal insulins in adults with type 2 diabetes.

Study context

Population
Adults with T2D, insulin-naive (ONWARDS 1, 3, 5) and insulin-experienced (ONWARDS 2, 4)5 RCTs
Comparison
Once-weekly icodec vs once-daily basal insulin
Primary endpoint
Proportion of hypoglycaemic episodes attributed to physical activity and OR of a physical activity-attributed hypoglycaemic episode, per trial
Methodological detailsfive separate randomised trials, phase 3a
  • Five separate randomised trials
  • Phase 3a

Primary result

As reported in the abstract

Physical activity-attributed hypoglycaemia

Incidence of physical activity-attributed clinically significant or severe hypoglycaemia in ONWARDS 1, 2, 3 and 5

≤3.0%

Further findings

Physical activity-attributed hypoglycaemic episodes, ONWARDS 4 (basal-bolus) — Icodec
18.6%
  • Physical activity-attributed hypoglycaemic episodes, ONWARDS 4 (basal-bolus): Insulin glargine U100 17.9%
  • Physical activity-attributed hypoglycaemic episodes, ONWARDS 4 (basal-bolus): numerically higher in both groups; expected given basal-bolus regimen

Recurrent clinically significant or severe hypoglycaemia within 24 h after a physical activity-attributed episode

Low frequency; none in ONWARDS 1, 3 and 5
0
ONWARDS 2 and 4: recurrent clinically significant episodes numerically higher with icodec vs once-daily comparators
No additional severe episodes in any participants across the trials

Original publication

The effect of once-weekly insulin icodec vs once-daily basal insulin on physical activity-attributed hypoglycaemia in type 2 diabetes: a post hoc analysis of ONWARDS 1–5. Diabetologia. Published 5 April 2025. doi:10.1007/s00125-025-06414-6

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.